Antitubercular Agents: Clinical Trials

3 trials of Antitubercular Agents, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

2 completed, 1 recruiting. 3 Phase 2, 1 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 23Completed 2, Recruiting 1
Phase 31Completed 1

Follow Antitubercular Agents: new trials by email Literature Review of Antitubercular Agents trials Research Report on Antitubercular Agents

Trials (filtered) newest first · largest first

All 3 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Adjunctive Doxycycline for Central Nervous System Tuberculosis
Doxycycline, Placebo, Anti Tuberculosis Drug - Tuberculosis, Meningeal, Tuberculosis; Meningitis (Etiology)
Phase 2RecruitingNational University Hospital, Singapore2002025-08-212026-06-01
The Effectivity of Anti Tuberculosis Therapy in Idiopathic Uveitis with Positive IGRA
Anti Tuberculosis Drug, Methylprednisolone - Tuberculous Uveitis
Phase 2CompletedFakultas Kedokteran Universitas Indonesia782021-08-272025-02-05
Empirical Treatment Against Cytomegalovirus and Tuberculosis in HIV-infected Infants With Severe Pneumonia
Valganciclovir Oral Solution [Valcyte], Tuberculostatic Agents - Pneumonia, HIV/AIDS
Phase 2 / Phase 3CompletedHospital Universitario 12 de Octubre5632020-03-012025-09-19

Conditions studied

Tuberculosis (3)  ·  Acquired Immunodeficiency Syndrome (1)  ·  Cytomegalovirus Infections (1)  ·  Meningitis (1)  ·  Meningoencephalitis (1)  ·  Pneumonia (1)  ·  Tuberculosis, Central Nervous System (1)  ·  Tuberculosis, Meningeal (1)  ·  Uveitis (1)

Sponsors

Fakultas Kedokteran Universitas Indonesia (1)  ·  Hospital Universitario 12 de Octubre (1)  ·  National University Hospital, Singapore (1)

Countries

Indonesia (2)  ·  Côte d’Ivoire (1)  ·  France (1)  ·  Italy (1)  ·  Malawi (1)  ·  Malaysia (1)  ·  Mozambique (1)  ·  Netherlands (1)  ·  Singapore (1)  ·  Spain (1)  ·  Uganda (1)  ·  United Kingdom (1)  ·  Zambia (1)  ·  Zimbabwe (1)

Top investigators

Cinta Moraleda, MD, PhD (1)  ·  Rina La Distia Nora, MD, PhD (1)

Results publications

PMID 35761406, PMID 36724434, PMID 40307889, PMID 41018498, PMID 42016921, PMID 42468541

NIH funding

2019 (1)